ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,514Medicare Part D Prescriptions Filled, Including Refills

Rank: 381 out of 2094

$566K Total Retail Price of All Prescriptions

Rank: 392 out of 2094

447 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 447 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 447 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 6,779 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 279 240 1 3
FUROSEMIDE 233 233 2 6
SIMVASTATIN 224 205 3 1
AMLODIPINE BESYLATE 195 185 4 2
ZOLPIDEM TARTRATE 193 177 5 14
SERTRALINE HCL 189 189 6 26
OMEPRAZOLE 173 173 7 4
DIOVAN 172 172 8 13
METOPROLOL TARTRATE 162 135 9 10
METOPROLOL SUCCINATE 156 152 10 9
DONEPEZIL HCL 150 150 11 20
ATORVASTATIN CALCIUM 133 131 12 5
HYDROCHLOROTHIAZIDE 114 98 13 12
LISINOPRIL 110 107 14 7
AZITHROMYCIN 107 93 15 27
PRAVASTATIN SODIUM 98 94 16 18
POTASSIUM CHLORIDE 97 94 17 24
FENTANYL 95 63 S2 18 68
WARFARIN SODIUM 93 91 19 11
LOSARTAN POTASSIUM 91 87 20 17
NAMENDA 90 90 21 32
DIGOXIN 89 61 22 51
ATENOLOL 87 87 23 21
FAMOTIDINE 76 76 24 34
OXYCODONE-ACETAMINOPHEN 75 37 S2 25 40
JANUVIA 70 67 26 35
GABAPENTIN 69 69 27 23
ESCITALOPRAM OXALATE 66 57 28 46
ISOSORBIDE MONONITRATE ER 63 63 29 57
CRESTOR 61 61 30 15
HYDROCODONE-ACETAMINOPHEN 61 44 S3 30 42
CLOPIDOGREL 59 59 32 22
OXYBUTYNIN CHLORIDE ER 57 52 33 138
CITALOPRAM HBR 55 54 34 47
IPRATROPIUM-ALBUTEROL 55 55 34 92
RAMIPRIL 53 53 36 48
METFORMIN HCL ER 52 28 37 67
PREDNISONE 52 48 37 54
TIZANIDINE HCL 51 0 39 254
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.